Selected Publications
Frazee, C.S., Chen, S., Berry, C.T., Lee, C.S., Banciella, R.A., Ngo, L., Shon, D., Herman, P.J., Fischman, J.S., Leff, C.L., Chen, A., Kuo, Y., Shestov, A.A., Kelly, A.R., Valentic, B., Milone, M.C., O'Connor, R.S., Ellebrecht, C.T. (2026). Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor costimulatory domains. Nat Immunol, doi: 10.1038/s41590-026-02548-w.
Ellebrecht, C. T., Maseda, D., & Payne, A. S. (2021). Pemphigus and Pemphigoid: From Disease Mechanisms to Druggable Pathways. Journal of Investigative Dermatology.
Ellebrecht, C. T., & Payne, A. S. (2014). Plakophilins, desmogleins, and pemphigus: the tail wagging the dog. Journal of Investigative Dermatology, 134(4), 874-876.
Ellebrecht, C. T., Choi, E. J., Allman, D. M., Tsai, D. E., Wegener, W. A., Goldenberg, D. M., & Payne, A. S. (2014). Subcutaneous veltuzumab, a humanized anti-CD20 antibody, in the treatment of refractory pemphigus vulgaris. JAMA dermatology, 150(12), 1331-1335.
Ellebrecht, C. T., Srinivas, G., Bieber, K., Banczyk, D., Kalies, K., Künzel, S., ... & Westermann, J. (2016). Skin microbiota-associated inflammation precedes autoantibody induced tissue damage in experimental epidermolysis bullosa acquisita. Journal of autoimmunity, 68, 14-22.
Ellebrecht, C. T., Bhoj, V. G., Nace, A., Choi, E. J., Mao, X., Cho, M. J., ... & Payne, A. S. (2016). Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science, 353(6295), 179-184.
Cho, M. J., Ellebrecht, C. T., Hammers, C. M., Mukherjee, E. M., Sapparapu, G., Boudreaux, C. E., ... & Payne, A. S. (2016). Determinants of VH1-46 cross-reactivity to pemphigus vulgaris autoantigen desmoglein 3 and rotavirus antigen VP6. The Journal of Immunology, 197(4), 1065-1073.
Ellebrecht, C. T., & Payne, A. S. (2017). Setting the target for pemphigus vulgaris therapy. JCI insight, 2(5).
Kasperkiewicz, M., Ellebrecht, C. T., Takahashi, H., Yamagami, J., Zillikens, D., Payne, A. S., & Amagai, M. (2017). Pemphigus. Nature reviews Disease primers, 3(1), 1-18.
Leibman, R. S., Richardson, M. W., Ellebrecht, C. T., Maldini, C. R., Glover, J. A., Secreto, A. J., ... & Riley, J. L. (2017). Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor. PLoS pathogens, 13(10), e1006613.
Ellebrecht, C. T., Mukherjee, E. M., Zheng, Q., Choi, E. J., Reddy, S. G., Mao, X., & Payne, A. S. (2018). Autoreactive IgG and IgA B cells evolve through distinct subclass switch pathways in the autoimmune disease pemphigus vulgaris. Cell reports, 24(9), 2370-2380.
Ellebrecht, C. T., Lundgren, D. K., & Payne, A. S. (2019). On the mark: genetically engineered immunotherapies for autoimmunity. Current opinion in immunology, 61, 69-73.
Lee, C. S., Chen, S., Berry, C. T., Kelly, A. R., Herman, P. J., Oh, S., O’Connor, R. S., Payne, A. S., & Ellebrecht, C. T. (2024). Fate induction in CD8 CAR T cells through asymmetric cell division. Nature, doi.org/10.1038/s41586-024-07862-7.